e-ISSN: Pending

Browse the failure-mode index

11,407 real negative results, null findings, and replication failures in Medicine · Negative / Null Result Report. Search the index →

WASTE indexes published research — it does not host or republish full papers. Each entry is a metadata record compiled from open scholarly databases; the abstract is shown in full only where the paper is openly licensed, otherwise a short excerpt under fair use. Classifications are automated and approximate.

Negative / Null Result ReportOpen accessMedicine

Parkinson's disease: pathogenesis and therapeutic strategies

Shanshan Zhang, Tingyu Wang, Ye Peng et al. · 2026 · Molecular Biomedicine

Parkinson's disease (PD) is a neurodegenerative disorder primarily characterized by motor impairments such as bradykinesia, tremor, and rigidity. Its neuropathological hallmarks include the progressive loss of dopaminergic neurons in the substantia nigra pars compacta (SNc) and the aggregation of α-synuclein (α-syn) into Lewy bodies (LBs), which gradually spread to other central nervous system regions and peripheral tissues. The etiology of PD is multifactorial, involving a complex interplay of genetic predisposition, aging, environmental exposures, and lifestyle factors. Disease pathogenesis

View details →
Negative / Null Result ReportMedicine

High-Flow or Standard Oxygen in Acute Hypoxemic Respiratory Failure

Jean-Pierre Frat, J. Quenot, Christophe Guitton et al. · 2026 · New England Journal of Medicine

BACKGROUND: Data are needed on the effect of oxygen delivered through a high-flow nasal cannula, as compared with standard oxygen therapy, on intubation and mortality in patients with acute hypoxemic respiratory failure. METHODS: In this…

View details →
Negative / Null Result ReportOpen accessMedicine

Impact of Etiology on Mortality and Recovery in Patients With Status Epilepticus

Pia De Stefano, Sira M. Baumann, Urs Fisch et al. · 2026 · Neurology

BACKGROUND AND OBJECTIVES: Although etiology is considered central to outcomes in status epilepticus (SE), previous studies often lacked standardized classification and adjustment for confounders, particularly withdrawal of life-sustaining treatment (WLST). This study examined the association between SE etiology, mortality, and neurologic recovery using the International League Against Epilepsy (ILAE) classification while accounting for confounders and WLST. METHODS: This 2-center observational study included adults (≥18 years) with SE treated at the University Hospitals of Basel and Geneva fr

View details →
Negative / Null Result ReportOpen accessMedicine

Neuroprotection in Parkinson Disease

Cristina Gonzalez‐Robles, Oliver Bandmann, Anthony H.V. Schapira · 2025 · Neurology and Therapy

Parkinson disease (PD) is a progressive neurodegenerative condition characterised by tremor, bradykinesia and rigidity, as well as other motor and non-motor symptoms, for which no effective disease-modifying treatments have been…

View details →
Negative / Null Result ReportOpen accessMedicine

Non-invasive temporal interference stimulation of the hippocampus suppresses epileptic biomarkers in patients with Epilepsy: biophysical differences between kilohertz and amplitude modulated stimulation

Florian Missey, Emma Acerbo, Adam S. Dickey et al. · 2025 · Brain stimulation

INTRODUCTION: Medication-refractory focal epilepsy creates a significant clinical challenge, with approximately 30 % of patients deemed ineligible for surgery due to involvement of eloquent cortical regions within the epileptogenic network. For these patients, electrical neuromodulation represents a promising alternative therapy. We investigated the potential of non-invasive temporal interference (TI) electrical stimulation in reducing epileptic biomarkers in patients with mesiotemporal epilepsy (MTLE) MATERIAL AND METHOD: Thirteen patients implanted with stereoelectroencephalography (sEEG) de

View details →
Negative / Null Result ReportOpen accessMedicine

Effect of Uncertainty-Aware AI Models on Pharmacists’ Reaction Time and Decision-Making in a Web-Based Mock Medication Verification Task: Randomized Controlled Trial

Corey A. Lester, Brigid Rowell, Yifan Zheng et al. · 2025 · JMIR Medical Informatics

Background: Artificial intelligence (AI)-based clinical decision support systems are increasingly used in health care. Uncertainty-aware AI presents the model's confidence in its decision alongside its prediction, whereas black-box AI only provides a prediction. Little is known about how this type of AI affects health care providers' work performance and reaction time. Objective: This study aimed to determine the effects of black-box and uncertainty-aware AI advice on pharmacist decision-making and reaction time. Methods: Recruitment emails were sent to pharmacists through professional listser

View details →
Negative / Null Result ReportOpen accessMedicine

Antibody drug conjugate targets are highly differentially expressed across the major types of ovarian cancer

Joanna M Porter, Cici Jin, Michael Churchman et al. · 2025 · European Journal of Cancer

BACKGROUND: Antibody-drug conjugates (ADCs) are emerging anti-cancer agents. The folate receptor alpha (FOLRα)-directed ADC mirvetuximab soravtansine recently demonstrated clinical activity in platinum-resistant ovarian cancer, with other ADCs currently in development. The relative expression of FOLRα and other ADC targets is largely unknown across ovarian cancer histotypes. METHODS: Expression levels of the ADC targets FOLRα, TROP2 and B7-H4 were assessed by immunohistochemistry in patient cohorts using tumour tissue microarrays of the major ovarian cancer histotypes: high grade serous (HGSOC

View details →
Negative / Null Result ReportOpen accessMedicine

Evaluating the role of CHG index in predicting stroke risk among adults with varying glucose regulation

Qun Xiao, WeiCheng Huang, Yuheng Zhuang et al. · 2025 · Aging Clinical and Experimental Research

BACKGROUND: Stroke is a significant public health issue, with its risk influenced by various metabolic factors. The Cholesterol, High-Density Lipoprotein, Glucose (CHG) index has been identified as a valid stroke predictor. However, the…

View details →
Negative / Null Result ReportOpen accessMedicine

Reducing contrast media dosage for pulmonary embolism CTPA in PCD-CT: a comparative study of EID-CT and PCD-CT in the era of individualized protocolling

Lion Stammen, Eva J I Hoeijmakers, Thomas G. Flohr et al. · 2025 · European Radiology

OBJECTIVES: To evaluate diagnostic image quality (IQ) for pulmonary embolism detection in photon-counting detector CT (PCD-CT) with significantly reduced contrast media (CM) dose vs conventional energy-integrating detector CT (EID-CT), using optimized and individualized CM protocols. MATERIALS AND METHODS: Consecutive CT pulmonary angiography (CTPA) scans performed on the EID-CT (Jan 2024-Mar 2024) with an individualized kilovoltage (kV) and total body weight (TBW) adapted CM protocol, and on the PCD-CT (Aug 2023-Feb 2024) with a TBW adapted CM protocol matching the 70 kV EID-CT protocol, were

View details →
Negative / Null Result ReportOpen accessMedicine

Nectin-4 PET for predicting enfortumab vedotin dose-response in urothelial carcinoma

Akhilesh Mishra, Ajay Sharma, Kuldeep Gupta et al. · 2026 · Science Advances

Optimizing dosing strategies is critical to balance effectiveness and toxicity, especially for drugs with narrow therapeutic windows such as antibody-drug conjugates (ADCs). This study evaluates whether positron emission tomography (PET) imaging targeting Nectin-4 can noninvasively quantify the real-time interaction of the ADC enfortumab vedotin (EV) with tumors in urothelial carcinoma. Using the imaging agent [ 68 Ga]AJ647, dynamic changes in the interaction of EV with Nectin-4 were measured across preclinical models and correlated with therapeutic responses. PET imaging identified dose-depen

View details →
Negative / Null Result ReportOpen accessMedicine

Cardiovascular Risk Assessment in Patients with Rheumatoid Arthritis

Ruxandra Oiegar, Dana Pop · 2025 · Journal of Clinical Medicine

Background/Objectives: Rheumatoid arthritis (RA) is a chronic inflammatory disease characterized by inflammation of the synovium. The inflammation accelerates the development and progression of atherosclerosis, a key phenomenon in the onset of cardiovascular diseases. The aim of this review was to synthetize the traditional and RA-specific cardiovascular risk (CVR) factors and the CVR assessment guidelines in RA patients. Methods: We performed a PubMed search using specific keywords. We synthetized the main findings. Results: Although the risk factors are the traditional ones, with certain par

View details →
Negative / Null Result ReportOpen accessMedicine

Vitamin D and Health Outcomes: State-of-the-Art Review of Triangulated Evidence and Ongoing Controversies

Maria Dalamaga, Rodopi Emfietzoglou, Dimitra Petropoulou et al. · 2026 · Current Nutrition Reports

PURPOSE OF REVIEW: Vitamin D is a pleiotropic hormone with an established role in skeletal integrity and broader actions in immune regulation, inflammation, cellular proliferation, and energy homeostasis. Despite decades of research, its extra-skeletal effects remain controversial, largely due to discordant findings across observational studies, Mendelian randomization studies (MRS), and randomized controlled trials (RCTs). Unlike many prior reviews, this state-of-the-art review synthesizes triangulated evidence across these study designs to clarify outcome-specific causal relationships and on

View details →
Negative / Null Result ReportOpen accessMedicine

Silybin A from Silybum marianum reprograms lipid metabolism to induce a cell fate-dependent class switch from triglycerides to phospholipids

Solveigh C. Koeberle, Maria Thürmer, Fengting Su et al. · 2025 · Theranostics

: Our study deciphers the structural features of silybin contributing to hepatic lipid remodeling and suggests that silymarin/silybin protects the liver in individuals with mild metabolic dysregulation, involving a lipid class switch from triglycerides to phospholipids, whereas it may be less effective in disease states associated with severe metabolic dysregulation.

View details →
Negative / Null Result ReportOpen accessMedicine

Remote Multicomponent Rehabilitation in Intensive Care Unit Survivors

Brenda M O'Neill, Judy Martina Bradley, Bronwen A. Connolly et al. · 2026 · JAMA

Importance: Evidence for remote multicomponent rehabilitation among critical care survivors is sparse. Objective: To investigate the effects of a 6-week, remote, multicomponent rehabilitation intervention in survivors of critical illness following discharge from the hospital after an intensive care unit (ICU) admission compared with standard care on health-related quality of life at 8 weeks. Design, Setting, and Participants: Pragmatic, multicenter, assessor-blinded, randomized clinical trial conducted from December 2022 to November 2025 at 52 National Health Service hospitals in the UK. Parti

View details →
Negative / Null Result ReportOpen accessMedicine

Mitochondrial Health Through Nicotinamide Riboside and Berberine: Shared Pathways and Therapeutic Potential

F Visalli, Matteo Capobianco, F. Cappellani et al. · 2026 · International Journal of Molecular Sciences

Mitochondrial dysfunction represents a central hallmark of aging and a broad spectrum of chronic diseases, ranging from metabolic to neurodegenerative and ocular disorders. Nicotinamide riboside (NR), a vitamin B3 derivative and efficient precursor of NAD+ (nicotinamide adenine dinucleotide), and berberine (BBR), an isoquinoline alkaloid widely investigated in metabolic regulation, have independently emerged as promising mitochondrial modulators. NR enhances cellular NAD+ pools, thereby activating sirtuin-dependent pathways, stimulating PGC-1α–mediated mitochondrial biogenesis, and triggering

View details →
Negative / Null Result ReportOpen accessMedicine

NANO-LM: An updated scorecard for the clinical assessment of patients with leptomeningeal metastases

Émilie Le Rhun, Lakshmi Nayak, Mary Jane Lim-Fat et al. · 2024 · Neuro-Oncology

BACKGROUND: There are no validated tools for the clinical neurological assessment of patients with leptomeningeal metastases (LM). However, clinical examination during the course of the disease guides medical management and is part of response assessment in clinical trials. Because neuroimaging may not always be obtained owing to rapid clinical deterioration, clinical neurological assessment of LM is essential, and standardization is important to minimize rater disagreement. METHODS: The Response Assessment in Neuro-oncology-LM group launched a 2-step process, aiming at improving and standardi

View details →
Negative / Null Result ReportOpen accessMedicine

Natural history of the revised ALS functional rating scale and its association with survival: the PRECISION-ALS Extant Study

Ruben P. A. van Eijk, Daphne N. Weemering, Sarah Opie-Martin et al. · 2025 · Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration

Objective To characterize the natural history of the revised ALS functional rating scale (ALSFRS-R) over a 24-month period following initial assessment, and to assess its associations with survival.Methods Longitudinal ALSFRS-R…

View details →
Negative / Null Result ReportOpen accessMedicine

Associations between the C-reactive protein-triglyceride glucose index and the incidence and progression trajectory of cardiometabolic multimorbidity: a multi-state model study

Lei Yuan, Zhe Zhao, Hongxiang Peng et al. · 2026 · Cardiovascular Diabetology

BACKGROUND: The C-reactive protein-triglyceride-glucose index (CTI) has been proposed as a novel biomarker for insulin resistance and inflammation. However, its role in the progression trajectory of cardiometabolic multimorbidity (CMM) remains unclear. We aimed to investigate the involvement of the CTI in the CMM progression trajectory. METHODS: This prospective study included 266,049 individuals from the UK Biobank, who were free of cardiometabolic diseases (CMD) at baseline. CMM was defined as the presence of two or more CMDs, including type 2 diabetes (T2D), coronary heart disease (CHD), an

View details →
Negative / Null Result ReportOpen accessMedicine

Cost-effectiveness of immunization strategies to protect infants against respiratory syncytial virus in the Netherlands

Annefleur C. Langedijk, Floris van den Dungen, Lisette M. Harteveld et al. · 2025 · Human Vaccines & Immunotherapeutics

The European Medicines Agency has authorized two interventions to prevent lower respiratory tract disease due to respiratory syncytial virus (RSV-LRTD) in infants: nirsevimab, a monoclonal antibody, and bivalent stabilized prefusion F…

View details →
Negative / Null Result ReportOpen accessMedicine

Deficient mismatch repair/microsatellite instability-high colorectal cancer: current treatment paradigms, limitations and future perspectives

Michael Harrison Storandt, Frank A. Sinicrope · 2026 · BMJ Oncology

The treatment paradigm for deficient mismatch repair (dMMR) colorectal cancer (CRC) has evolved substantially in recent years. Universal mismatch repair testing and broad use of next-generation sequencing have increased the detection of…

View details →
Negative / Null Result ReportOpen accessMedicine

Learning with Generative AI: An Empirical Study of Students in Higher Education

Golan Carmi · 2025 · Education Sciences

Generative AI technologies are rapidly permeating higher education as innovative tools that support teaching and learning processes. This study investigates the integration of GenAI tools into academic learning and examines their influence on students’ learning effectiveness, attitudes, and satisfaction. A quantitative survey was administered to 485 college students. The findings indicate that students’ attitudes, satisfaction, and accumulated experience with GenAI constitute the most influential factors in promoting effective learning. Perceived advantages and disadvantages also play a substa

View details →
Negative / Null Result ReportOpen accessMedicine

Performance and challenges of malaria rapid diagnostic tests in endemic regions of Africa

Fiyinfoluwa Demilade Ojeniyi, Adeola Oluwakemi Ayoola, Olajumoke Ibitoye et al. · 2025 · Scientific Reports

Rapid diagnostic tests (RDTs) have revolutionized malaria diagnosis, playing a crucial role in improving timely treatment and supporting surveillance efforts, especially in resource-limited settings. However, the performance of RDTs can…

View details →
Negative / Null Result ReportOpen accessMedicine

Neoadjuvant Single-Cycle Pembrolizumab for Stage I-III MMR-Deficient Colon Cancer: The RESET-C Trial

Ismail Gögenür, Tobias Freyberg Justesen, Line Schmidt Tarpgaard et al. · 2026 · Journal of Clinical Oncology

PURPOSE: Neoadjuvant immune checkpoint inhibition has shown promise in localized deficient mismatch repair (dMMR) colorectal cancer, yet the optimal treatment duration, regimen, and methods for response evaluation remain undefined. This trial aimed to investigate the efficacy and safety of neoadjuvant pembrolizumab for patients with localized dMMR colon cancer. METHODS: Participants received a single cycle of pembrolizumab (4 mg/kg, max 400 mg, every-6-weeks dosing regimen), followed by a preoperative endoscopy with biopsies and surgery 3-5 weeks later. The primary end point was pathologic com

View details →
Negative / Null Result ReportOpen accessMedicine

Performance of adult-trained artificial intelligence models in paediatric imaging—a scoping review

Lene Bjerke Laborie, Jennifer Lee, Edward Antram et al. · 2026 · European Radiology

OBJECTIVES: This scoping review aims to evaluate the performance of artificial intelligence (AI) models designed for adults when applied to paediatric imaging datasets without additional adaptations, and to quantify performance degradation across different modalities, use-cases and age groups. MATERIALS AND METHODS: A literature search was conducted covering 10 years (1/01/2014-23/06/2025) using terms relating to "child", "adult", "artificial intelligence", "radiology" and "validation/performance". Two reviewers independently extracted data using standardised templates and conducted a narrativ

View details →
Negative / Null Result ReportOpen accessMedicine

Dasatinib and quercetin senolytic treatment delays early onset intervertebral disc degeneration in SM/J mice

Emanuel J. Novais, Olivia K. Ottone, Sanjana Jagannath et al. · 2026 · Bone Research

Genetic background is a major determinant of disc degeneration, a leading cause of chronic back pain and disability. Herein, we demonstrate that premature disc cell senescence contributes to early-onset degeneration in SM/J mice and test two systemic senotherapeutic strategies to mitigate it: Navitoclax (Nav.) and a cocktail of Dasatinib and Quercetin (DQ). While Nav. treatment did not improve severe degeneration in SM/J mice or senescence status, DQ-treated mice showed lower grades of degeneration and a decreased abundance of senescence markers, including p19ARF, p21, and the senescence-assoc

View details →
Negative / Null Result ReportOpen accessMedicine

Current Drug Development Pipeline for MASLD and MASH: Focusing on Cardiovascular Comorbidities

Приходько Вероника Александровна, Sergey V. Okovityi · 2026 · Biomedicines

Metabolic dysfunction-associated steatotic liver disease (MASLD) is characterized by an exceptionally high global prevalence that is projected to continue rising in the near future. MASLD is strongly associated with a spectrum of cardiometabolic risk factors, and may itself, in turn, contribute to cardiovascular morbidity and mortality. This interconnection warrants the development of integrated treatment strategies targeting shared pathophysiological processes and addressing both hepatic, metabolic, and cardiovascular outcomes. In this work, we review the modern MASLD clinical development pip

View details →
Negative / Null Result ReportOpen accessMedicine

GLP‐1 at the Metabolic–Cognitive Interface: Reward, Affect, and Memory

Shangkai Gao, Léa Décarie-Spain, Cindy Gu et al. · 2026 · Comprehensive physiology

Glucagon-like peptide-1 (GLP-1) is a nutrient-responsive hormone classically associated with glucose homeostasis and food intake control, yet its receptor is broadly expressed throughout the central nervous system (CNS) in circuits governing complex cognitive processes. Here, we synthesize emerging evidence from preclinical models and human studies demonstrating that GLP-1 receptor (GLP-1R) signaling modulates multiple cognitive domains, including reward and motivational processes relevant to obesity and substance use disorder, affective-related behaviors, and learning and memory. We propose a

View details →